Yervoy (ipilimumab)

Yervoy (ipilimumab) is a kinase inhibitor indicated for the treatment of:

– advanced (unresectable or metastatic) melanoma
– cutaneous melanoma
– previously untreated advanced renal cell carcinoma
– microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer

This medicine is not (yet) part of our standard product range but we can usually get it for you. Please contact us to verify price and availability.